(Q34275917)

English

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Epstein–Barr virus

0 references

organ transplantation

1 reference

based on heuristic

inferred from title

1

object named as

Green M

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Reyes J

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Webber S

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Rowe D

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

97-103

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preemptive Therapy in Immunocompromised Hosts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretransplantation assessment of the risk of lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003002097.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-3062.2001.003002097.X

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34275917&oldid=2041885906"